Description
The ProbeSeq BNP PeptideProbe™ Targeting System provides sequence-engineered peptide ligands designed for high-affinity recognition of B-type Natriuretic Peptide (BNP), a clinically important biomarker for cardiac stress and heart failure. The system supports rapid and selective biomarker capture for diagnostic assay development, point-of-care testing platforms, and microfluidic detection technologies.
Peptide probes offer strong binding specificity, structural stability, and reproducible performance across fluorescence, electrochemical, and lateral-flow detection systems. The platform enables integration into multiplex cardiac panels and portable diagnostic devices.
Molecular Detection Mechanism
Target recognition occurs through selective peptide–protein binding interactions with BNP molecules. Binding events enable signal generation through labeled reporters or sensor surface interactions, allowing quantitative detection across multiple assay formats.
The system supports direct biomarker detection or signal amplification workflows, providing stable target capture and minimal non-specific binding.
Target Design Strategy
Peptide sequences are engineered to ensure:
-
High affinity and specificity for BNP
-
Minimal cross-reactivity with related natriuretic peptides
-
Stable structural conformation
-
Compatibility with biosensor and microfluidic integration
-
Robust performance in complex biological samples
Assay Workflow Integration
Compatible with standard immunoassay-like workflows, biosensor platforms, and microfluidic cartridges. Detection can be performed using fluorescence readers, electrochemical sensors, or lab-on-chip systems.
Research Applications
-
Heart failure diagnostic development
-
Cardiac biomarker detection research
-
Biosensor engineering
-
Microfluidic diagnostic systems
-
Multiplex cardiovascular panels
-
Point-of-care testing technology development
